Cancer Research Technology
Log in Register
Menu

Anti-PAX-FOXO1 [PaxF] monoclonal antibody

Invented at National Human Genome Research Institute

Info

Catalogue Number 160866
Applications ChIP IHC IF IP WB ChIP-seq
Antigen/Gene or Protein Targets the junction region of the PAX3-FOXO1 and the PAX7-FOXO1 fusion proteins
Synonyms PFM.2
Reactivity Human
Relevance Alveolar Rhabdomyosarcoma (ARMS) is an aggressive pediatric cancer and cases with fusion oncoproteins PAX7-FOXO1 and PAX3-FOXO1 have a poor prognosis. Determination of the fusion status is important for RMS diagnostics and therapies. This antibody is specific for the PAX3-FOXO1 and PAX7-FOXO1 and therefore is a valuable tool to study the oncogenesis of ARMS.
Host Mouse
Immunogen KLH conjugated with peptide PF corresponding to the PAX3-FOXO1 translocation region aa 100-117 (TIGNGLSPQNSIRHNLSL) in Freund’s adjuvant
Positive Control Cell lysate from FP-RMS lines (e.g., RH-4, RH-28, RH-30, RMS-13)
Subclass IgG2b kappa
Molecular Weight (kDa) 105
Myeloma Used P3X63Ag8.653
Strain Balb/c
Research Area Cancer

References

There are 4 reference entries for this reagent.

View All References

References: 4 entries

Azorsa et al. 2021. Mod Pathol. 34(4):748-757. PMID: 33299109.

Gryder et al. 2017. Cancer Discov. 7(8):884-899. PMID: 28446439.

Cao et al. 2010. Cancer Res. 70(16):6497-508. PMID: 20663909.

Khan et al. 1999. Proc Natl Acad Sci U S A. 96(23):13264-9. PMID: 10557309.


Add a reference

References: 4 entries

Azorsa et al. 2021. Mod Pathol. 34(4):748-757. PMID: 33299109.

Gryder et al. 2017. Cancer Discov. 7(8):884-899. PMID: 28446439.

Cao et al. 2010. Cancer Res. 70(16):6497-508. PMID: 20663909.

Khan et al. 1999. Proc Natl Acad Sci U S A. 96(23):13264-9. PMID: 10557309.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor